You are here: Industry Insights > COVID-19

News List

FDA revokes authorisation for anti-malarials to treat Covid-19 pharmaceutical-technology
June 16, 2020
The US Food and Drug Administration (FDA) has revoked the emergency use authorisation (EUA) for anti-malarials, chloroquine phosphate and hydroxychloroquine sulfate, to treat some hospitalised Covid-19 patients.
Trial for new ibuprofen formulation as COVID-19 treatment launched in UK europeanpharmaceuticalreview
June 16, 2020
A unique formulation of ibuprofen is being tested as a treatment for severe acute respiratory distress syndrome (ARDS), a symptom of COVID-19.
Regeneron Begins Clinical Trials of Anti-Viral Antibody Cocktail contractpharma
June 16, 2020
REGN-COV2 is targeted specifically against SARS-CoV-2.
Grifols Begins Production of Anti-SARS-CoV-2 Hyperimmune Immunoglobulin contractpharma
June 16, 2020
Potential anti-COVID-19 passive immune therapy is part of a collaboration with the U.S. government, first doses for trials are expected July 2020.
FDA Authorizes Next-Gen Sequence Test for Diagnosing COVID-19 contractpharma
June 16, 2020
The FDA authorized the Illumina COVIDSeq Test for the qualitative detection of SARS-CoV-2 RNA from respiratory specimens collected from individuals suspected of COVID-19.
Catalent, AstraZeneca Ink Mfg. Pact for COVID-19 Vax contractpharma
June 16, 2020
Catalent preparing for large-scale commercial supply of the University of Oxford’s COVID-19 vaccine candidate AZD1222 starting August 2020.
1 In 2 Americans Say COVID-19 Has Changed The Way They Use Healthcare prnewswire
June 16, 2020
COVID-19 is changing American consumer behavior. A recent healthinsurance.com consumer pulse survey finds that 48% have changed the way they use healthcare during the COVID-19 pandemic.
PolyU collaborates with Macau, S.A.R., China University of Science and Technology to advance diagnosis of COVID-19 pneumonia prnewswire
June 16, 2020
COVID-19 is taking its toll on the world, affecting more than 200 countries and regions. In the face of a surge in cases, rapid diagnosis and identification of high-risk patients for early intervention is crucial for controlling the pandemic.
Immunic, Inc. Announces First Patients Dosed in its Phase 2, CALVID-1 Clinical Trial of IMU-838 in COVID-19 prnewswire
June 16, 2020
Immunic, Inc., a clinical-stage biopharmaceutical company focused on developing best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases.
Lilly Begins a Phase 3 Clinical Trial with Baricitinib for Hospitalized COVID-19 Patients prnewswire
June 16, 2020
Eli Lilly and Company announced that the first patient has been enrolled in a Phase 3 randomized, double-blind, placebo–controlled study to evaluate the efficacy and safety of baricitinib, an oral JAK1/JAK2 inhibitor licensed from Incyte, ...